4350
MEDICAL SYSTEM NETWORK Co.,Ltd.
メディカルシステムネットワーク
- Industry
- Retail Trade
- Market
- Standard
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(million JPY)
Mar 2022
106,685
Mar 2023
109,551
Mar 2024
115,361
Mar 2025
122,387
Mar 2026
132,186
Operating profit(million JPY)
Mar 2022
3,852
Mar 2023
3,163
Mar 2024
3,832
Mar 2025
3,154
Mar 2026
3,313
Operating profit margin(%)
Mar 2022
3.61
Mar 2023
2.89
Mar 2024
3.32
Mar 2025
2.58
Mar 2026
2.51
Profit before tax(million JPY)
Mar 2022
4,012
Mar 2023
3,019
Mar 2024
3,451
Mar 2025
2,724
Mar 2026
2,552
Profit(million JPY)
Mar 2022
2,394
Mar 2023
1,610
Mar 2024
1,860
Mar 2025
1,262
Mar 2026
1,070
Total assets(million JPY)
Mar 2022
62,941
Mar 2023
66,223
Mar 2024
68,149
Mar 2025
70,586
Mar 2026
80,100
Cash and cash equivalents(million JPY)
Mar 2022
8,171
Mar 2023
8,111
Mar 2024
8,242
Mar 2025
8,431
Mar 2026
7,743
Cash flows from operating activities(million JPY)
Mar 2022
4,010
Mar 2023
4,973
Mar 2024
7,725
Mar 2025
4,459
Mar 2026
-3,441
Cash flows from investing activities(million JPY)
Mar 2022
-2,511
Mar 2023
-2,114
Mar 2024
-3,649
Mar 2025
-3,726
Mar 2026
-4,036
Cash flows from financing activities(million JPY)
Mar 2022
-3,415
Mar 2023
-2,918
Mar 2024
-3,944
Mar 2025
-544
Mar 2026
6,789
Return on equity(%)
Mar 2022
19.6
Mar 2023
11.6
Mar 2024
12.6
Mar 2025
8
Mar 2026
6.4
Equity ratio(%)
Mar 2022
21.1
Mar 2023
21.8
Mar 2024
22.3
Mar 2025
23
Mar 2026
21.6
Earnings per share(JPY per share)
Mar 2022
79.35
Mar 2023
53.38
Mar 2024
61.89
Mar 2025
43.2
Mar 2026
36.64
Net assets per share(JPY per share)
Mar 2022
439.67
Mar 2023
478.86
Mar 2024
519.06
Mar 2025
556.31
Mar 2026
591.38
Dividend per share(JPY per share)
Mar 2022
12
Mar 2023
12
Mar 2024
12
Mar 2025
12
Mar 2026
12
Payout ratio(%)
Mar 2022
15.12
Mar 2023
22.48
Mar 2024
19.39
Mar 2025
27.78
Mar 2026
32.75
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.